Binding of ligands and activation of transcription by nuclear receptors

Annual Review of Biophysics and Biomolecular Structure

Volumn 30, Issue , 2001, Pages 329-359

  Steinmetz, A C U ^a   Renaud, J P ^a   Moras, D ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Antagonism; Conformational change; Isotype specificity; Mechanism of activation; Partial agonism

Indexed keywords

CELL NUCLEUS RECEPTOR; DNA BINDING PROTEIN; LIGAND; TRANSCRIPTION FACTOR;

AGONIST; BINDING SITE; CONFORMATIONAL TRANSITION; DNA BINDING; GENETIC TRANSCRIPTION; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN TERTIARY STRUCTURE; REVIEW; TRANSCRIPTION INITIATION;

ANIMALS; CELL NUCLEUS; DNA; HUMANS; LIGANDS; MODELS, BIOLOGICAL; MODELS, CHEMICAL; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION, GENETIC;

EID: 0034984748     PISSN: 10568700     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.biophys.30.1.329     Document Type: Review

References (75)

1. Disruption of retinoid-related orphan receptor beta changes circadian behavior, causes retinal degeneration and leads to vacillans phenotype in mice
2. Differential response of estrogen receptor-α and estrogen receptor-β to partial estrogen agonists/antagonists
3. Synergy between estrogen receptor α activation functions AF1 and AF2 mediated by transcription intermediary factor TIF2
4. Crystal structure of the ligand binding domain of the ultraspiracle protein USP, the ortholog of RXRs in insects
5. Retinoic acid receptor: A simulation analysis of retinoic acid binding and the resulting conformational changes
6. Structure-function relationships in the vitamin D endocrine system
7. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains
8. Molecular basis of agonism and antagonism in the oestrogen receptor
9. A transcriptional co-repressor that interacts with nuclear hormone receptors
10. Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7
11. Structure and specificity of nuclear receptor:coactivator interactions
12. New versus old fashioned oestradiol antagonists in mammary carcinoma: 'In vitro' and 'in vivo' pharmacological approaches
13. Two receptor interaction domains in the corepressor, N-CoR/RIP13, are required for an efficient interaction with Rev-erbA alpha and RVR: Physical association is dependent on the E region of the orphan receptors
14. Effect of single and compound knockouts of estrogen receptors α (ERα) and β (ERβ) on mouse reproductive phenotypes
15. Crystal structure of the human RXRα ligand-binding domain bound to its natural ligand: 9-cis retinoic acid
16. An ecdysteroid-responsive gene in a lobster - A potential crustacean member of the steroid hormone receptor superfamily
17. Statistical thermodynamic linkage between conformational and binding equilibria
18. Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta
19. Asymmetry in the PPARγ/RXRα crystal structure reveals the molecular basis of heterodimerization among nuclear receptors
20. Crystal structure of a mutant hERα LBD reveals key structural features for the mechanism of partial agonism
21. p300 interacts with the N- and C-terminal part of PPARgamma2 in a ligand-independent and -dependent manner, respectively
22. Orphan nuclear receptors: From gene to function
23. The coregulator exchange in transcriptional functions of nuclear receptors
24. Molecular determinants of tissue selectivity in estrogen receptor modulators
25. Transcription factors 3: Nuclear receptors
26. Disruption of the nuclear hormone receptor RORalpha in staggerer mice
27. The vitamin D hormone and its nuclear receptor: Molecular actions and disease states
28. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors
29. Ligand-induced stabilisation of PPARγ monitored by NMR spectroscopy: Implications for nuclear receptor activation
30. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB
31. Nonsteroid nuclear receptors: What are genetic studies telling us about their role in real life?
32. Enantiomer discrimination illustrated by high-resolution crystal structures of the human nuclear receptor hRARγ
33. Structural basis for isotype selectivity of the human retinoic acid nuclear receptor
34. Conformational adaptation of agonists to the human nuclear receptor RARγ
35. Targets of activated steroid hormone receptors: Basal transcription factors and receptor interacting proteins
36. Orphan nuclear receptors: Shifting endocrinology into reverse
37. p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor α and β by interacting directly with the N-terminal A/B domains
38. Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors alpha and gamma through the ubiquitin-proteasome pathway
39. CHR3: A Caenorhabditis elegans orphan nuclear hormone receptor required for proper epidermal development and molting
40. Activation of a delayed-early gene encoding MHR3 by the ecdysone receptor heterodimer EcR-B1 USP-1 but not by EcR-B1-USP-2
41. Evolution of the nuclear receptor superfamily: Early diversification from and ancestral orphan receptor
42. The 26S proteasome is required for estrogen receptor-α and coactivator turnover and for efficient estrogen receptor-α transactivation
43. Basic guide to the mechanisms of antiestrogen action
44. The RXR heterodimers and orphan receptors
45. Cloning and characterization of new orphan nuclear receptors and their developmental profiles during Tenebrio metamorphosis
46. Human estrogen receptor ligand activity inversion mutants: Receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens
47. The corepressor N-CoR and its variants RIP13a and RIP13Delta1 directly interact with the basal transcription factors TFIIB, TAFII32 and TAFII70
48. Recent developments in receptor-selective retinoids
49. Mechanism of corepressor binding and release from nuclear hormone receptors
50. A second CYP26 P450 in humans and zebrafish: CYP26B1
51. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
52. A unified nomenclature system of the superfamily of nuclear receptors
53. A peroxisome proliferator-activated receptor γ ligand inhibits adipocyte differentiation
54. Molecular determinants of nuclear receptor-corepressor interaction
55. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist
56. Cytochromes P450 in synthesis of steroid hormones, bile acids, vitamin D3 and cholesterol
57. The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signalling via MAP kinase
58. A model for the cytoplasmic trafficking of signalling proteins involving the hsap90-binding immunophilins and p50cdc37
59. Structure-function analysis of the rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains
60. Structural studies on nuclear receptors
61. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid
62. Nongenomic actions of steroid hormones in reproductive tissues
63. The crystal structure of the nuclear receptor for vitamin D bound its natural ligand
64. Stimulation of RAR alpha activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7
65. Oestrogen receptor facilitates the formation of preinitiation complex assembly: Involvement of the general transcription factor TFIIB
66. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
67. Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands
68. Crystal structure of the ligand binding domain of the human nuclear receptor PPARγ
69. A structural role for hormone in the thyroid hormone receptor
70. Coordination of Drosophila metamorphosis by two ecdysone-induced nuclear receptors
71. Atomic structure of progesterone complexed with its receptor
72. A canonical structure for the ligand-binding domain of nuclear receptors
73. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors
74. Localization and functions of steroid hormone receptors